Additionally, upregulation of LINC00839 significantly reversed miR-454-3p-induced promoting role in NPC cells in vitro, implying a novel LINC00839/miR-454-3p signaling axis in NPC development. The gene discussed is LINC00839; the disease is nasopharyngeal carcinoma.